Thermo Fisher Scientific Inc.
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Reported Revenue Growth by Year
Reported Revenue Growth — Laboratory Products & Biopharma Services (%)
Thermo Fisher Scientific Reported Revenue Growth: 4.0% in FY2025, up 3.0 pts from a year earlier.
Where the FY2025 figure comes from
“LPBS: Total revenue growth -1% 4% 4% 7% 4% 7% 12% 15%”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package & SEC MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Reported Revenue Growth — Laboratory Products & Biopharma Services (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.0% | +3.0 pts | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 1.0% | -1.0 pts | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 2.0% | -49.0 pts | Q4 & FY2024 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 51.0% | – | SEC Form 10-K (10k_2022, filed 2023-02-23) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Reported Revenue Growth (%), annual FY2022–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/org-reported-pct-lpbs
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.